Back to Search Start Over

Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates.

Authors :
Gersin KS
Rothstein RI
Rosenthal RJ
Stefanidis D
Deal SE
Kuwada TS
Laycock W
Adrales G
Vassiliou M
Szomstein S
Heller S
Joyce AM
Heiss F
Nepomnayshy D
Source :
Gastrointestinal endoscopy [Gastrointest Endosc] 2010 May; Vol. 71 (6), pp. 976-82. Date of Electronic Publication: 2010 Mar 20.
Publication Year :
2010

Abstract

Background: The duodenojejunal bypass liner (DJBL) (EndoBarrier Gastrointestinal Liner) is an endoscopically placed and removable intestinal liner that creates a duodenojejunal bypass resulting in weight loss and improvement in type 2 diabetes mellitus.<br />Objective: Weight loss before bariatric surgery to decrease perioperative complications.<br />Design: Prospective, randomized, sham-controlled trial.<br />Setting: Multicenter, tertiary care, teaching hospitals.<br />Patients: Twenty-one obese subjects in the DJBL arm and 26 obese subjects in the sham arm composed the intent-to-treat population.<br />Interventions: The subjects in the sham arm underwent an EGD and mock implantation. Both groups received identical nutritional counseling.<br />Main Outcome Measurements: The primary endpoint was the difference in the percentage of excess weight loss (EWL) at week 12 between the 2 groups. Secondary endpoints were the percentage of subjects achieving 10% EWL, total weight change, and device safety.<br />Results: Thirteen DJBL arm subjects and 24 sham arm subjects completed the 12-week study. EWL was 11.9% +/- 1.4% and 2.7% +/- 2.0% for the DJBL and sham arms, respectively (P < .05). In the DJBL arm, 62% achieved 10% or more EWL compared with 17% of the subjects in the sham arm (P < .05). Total weight change in the DJBL arm was -8.2 +/- 1.3 kg compared with -2.1 +/- 1.1 kg in the sham arm (P < .05). Eight DJBL subjects terminated early because of GI bleeding (n = 3), abdominal pain (n = 2), nausea and vomiting (n = 2), and an unrelated preexisting illness (n = 1). None had further clinical symptoms after DJBL explantation.<br />Limitations: Study personnel were not blinded. There was a lack of data on caloric intake.<br />Conclusions: The DJBL achieved endoscopic duodenal exclusion and promoted significant weight loss beyond a minimal sham effect in candidates for bariatric surgery. (<br />Clinical Trial Registration Number: NPT00469391.).<br /> (2010 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.)

Details

Language :
English
ISSN :
1097-6779
Volume :
71
Issue :
6
Database :
MEDLINE
Journal :
Gastrointestinal endoscopy
Publication Type :
Academic Journal
Accession number :
20304396
Full Text :
https://doi.org/10.1016/j.gie.2009.11.051